“In In­dia till now, Biore­search is con­sid­ered to be a bit costly”

BioSpectrum (India) - - BIO CONTENT - « Dr Ashes Gan­guly Pres­i­dent, In­dian An­a­lyt­i­cal In­stru­ment As­so­ci­a­tion (IAIA)

Dr Ashes Gan­guly, founder Di­rec­tor of Cryo­gen In­stru­ments In­dia, one of the lead­ing sup­pli­ers of Spe­cial­ity/Iso­topic Gases and Nu­clear Medicines in the coun­try, is head­ing the In­dian An­a­lyt­i­cal In­stru­ment As­so­ci­a­tion (IAIA) as pres­i­dent since 2015 till 2018. In an in­ter­ac­tion with BioSpec­trum he shares his views as Pres­i­dent of IAIA on gov­ern­ment’s Make in In­dia scheme and GST etc. Ex­perts of the in­ter­view

Ac­cord­ing to you, what are the trends in bio­sup­pli­ers market with re­spect to life sci­ences and health­care in­dus­try in In­dia?

The Bio-sup­pli­ers market in In­dia is cer­tainly grow­ing at an aver­age rate of 10%+ for the Life sci­ence and Health­care in­dus­try in In­dia. But it is cer­tainly not grow­ing as ex­pected.

How many com­pa­nies (man­u­fac­tur­ers and dis­trib­u­tors) are cur­rently op­er­at­ing in this space?

There are few 100’s of com­pa­nies that are op­er­at­ing in In­dia ei­ther has a distrib­u­tor or man­u­fac­turer but might be only a cou­ple of dozen com­pa­nies are hav­ing a turn over more than $ 10 mil­lion.

Ac­cord­ing to you how many peo­ple are en­gaged (be­ing em­ployed with com­pa­nies) in this space and do you see the in­dus­try will ab­sorb more can­di­dates in the com­ing pe­riod?

Keep­ing a part of CRO & Clin­i­cal Re­search there are around 10K+ em­ploy­ees in this in­dus­try but there is no def­i­nite data in our hand from which we can con­clude the ex­act num­bers. For that it’s a her­culean ex­er­cise which we have to per­form to get the ex­act num­bers wherein all com­pa­nies should be trans­par­ent to share the em­ployee strength as well as turn over too.

How do you see the op­por­tu­ni­ties for Bio sup­pli­ers for life sci­ences and health­care in­dus­try?

As we said ear­lier that the growth is around 10%+ on an aver­age so the Life sci­ences and Health­care op­por­tu­ni­ties is quite op­ti­mistic com­pared to the aver­age world growth.

With gov­ern­ment of In­dia launch­ing In­no­vate in In­dia (i3) pro­gram, how do you see the growth of the in­dus­try?

It’s too early to make any state­ment but we ap­pre­ci­ate the pos­i­tive steps taken by the Govt. of In­dia.

Which are the ma­jor seg­ments of bio­sup­pli­ers? How do you see the growth of these seg­ments?

DNA Se­quenc­ing, Struc­tural elu­ci­da­tions, Stem Cells, Gene map­ping etc. are the real chal­lenges and ex­cit­ing fields for bio re­search now. The growth can be quite sig­nif­i­cant pro­vided the ac­cep­tance and stan­dard­iza­tions set­tle fast.

What are ma­jor chal­lenges be­fore bio­sup­pli­ers in­dus­try?

In In­dia till now, Biore­search is con­sid­ered to be a bit costly and high end re­search field, as long as it per­co­lates down to more uni­ver­si­ties and re­search ori­ented in­sti­tutes com­pared to US, Europe and Ja­pan it will re­main as a chal­lenge like other re­search seg­ments.

What are your views on GST?

GST as all of us are aware it’s a process of stan­dard­iza­tions and uni­fi­ca­tions of the Tax struc­ture in In­dia, so we ex­pect it will ben­e­fit the con­sumers as well as the sup­pli­ers too at large in the long run, but there are some few chal­lenges that we are fac­ing dur­ing the time of im­ple­men­ta­tions al­though I am sure if we have a

trans­parency and com­mit­ment to­wards it, GST will be suc­cess­ful in In­dia in the near fu­ture.

What are your views on gov­ern­ment’s Make in In­dia scheme?

It’s al­ways wel­come, the Gov­ern­ment’s view of Make in In­dia scheme, but we in­dus­try play­ers need to un­der­stand that we are niche play­ers with High Tech­nol­ogy In­puts which till now the In­dian in­fra­struc­ture of pro­duc­tion process doesn’t sup­port very well. So we have to col­lec­tively work to­wards that first and then look at Make In­dia ini­tia­tive in our field. In ad­di­tion any prod­uct we man­u­fac­ture un­til and un­less its Glob­ally ac­cepted it will be never be suc­cess­ful in to­day’s busi­ness sce­nario in num­bers. So we have to look into on that then only we will get the success of dom­i­nance in our in­dus­try.

In­dia still is a ma­jor im­porter of high-end equip­ment/ in­stru­ments used in life sci­ences R&D and man­u­fac­tur­ing. Ac­cord­ing to you how In­dia can build its own bio­sup­pli­ers in­dus­try?

Till now our In­dus­try is im­port based. How­ever there are very few ini­tia­tives that are tak­ing place for man­u­fac­tur­ing our prod­uct in In­dia in re­cent times, but as an as­so­ci­a­tion we will re­main open to sup­port any good cause of pro­duc­tiv­ity. At first we have to give em­pha­sis on the ed­u­ca­tion level, where our next gen­er­a­tion stu­dents rather than mi­grat­ing abroad, should be ready to give their time, tal­ent and in­puts to the coun­try, si­mul­ta­ne­ously our in­vestors have to be open to give due com­pen­sa­tions and bet­ter R&D en­vi­ron­ment. Thirdly the com­pany’s mar­ket­ing and ser­vice sup­port team should be glob­ally ex­posed. So there are a cou­ple of is­sues, un­til and un­less all facets of ac­tiv­i­ties is up to the global stan­dard it will be very dif­fi­cult for us to be a dom­i­nant force in the global market. Which we as an as­so­ci­a­tion are tak­ing a few ini­tia­tives, but I feel these type of results can only come af­ter a decade.

Dr Ashes Gan­guly Pres­i­dent, In­dian An­a­lyt­i­cal In­stru­ment As­so­ci­a­tion (IAIA)

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.